MEX3A and breast carcinoma: In breast cancer tissues, MEX3A protein expression was strongly positive in 46.51% of the total samples, weakly positive in 23.26% of the total samples, and negative in 30.23% of the total samples, suggesting that MEX3A expression in breast cancer may be upregulated (Figure 1(b,c)).